Clinical Study of Nanocrystalline Megestrol in Malnourished Patients With First-Line Non-Small Cell Lung Cancer

NCT06828757 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: nanocrystalline megestrol oral suspension + PD-1/L1 inhibitor combined with chemotherapy
DRUG: PD-1/L1 inhibitor combined with chemotherapy

Sponsor

Hunan Province Tumor Hospital